About
Allogeneic, Off-The-Shelf, Multi-Virus Specific T-Cell Immunotherapies
Areas of Focus
Categories
Stem Cell & Cellular Therapy
Team (13)
Andrew Oxtoby
CEO & Director
Kolaris Therapeutics
executive
Anthony Adamis, MD
Director
Kolaris Therapeutics
team_member
Brett Hagen, CPA
SVP Finance & CAO
Kolaris Therapeutics
team_member
David Hallal
Board Chairman
Kolaris Therapeutics
board_chair
Jill Porter
VP CMC
Kolaris Therapeutics
executive
Kristine Curtiss
SVP Clinical
Kolaris Therapeutics
team_member
Locations (1)
Headquarters
Virtual, US
Map
Loading map...